SARS-CoV-2 structural features may explain limited neutralizing-antibody responses

被引:44
作者
Bachmann, Martin F. [1 ,2 ,3 ]
Mohsen, Mona O. [2 ,3 ]
Zha, Lisha [1 ]
Vogel, Monique [1 ]
Speiser, Daniel E. [4 ,5 ]
机构
[1] Anhui Agr Univ, Int Immunol Ctr, Hefei, Peoples R China
[2] Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland
[3] Univ Bern, Dept BioMed Res, Bern, Switzerland
[4] Univ Hosp, Lausanne, Switzerland
[5] Univ Lausanne, Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
CORONAVIRUS; IMMUNITY; CELL; ANTIGEN; IMMUNOGENICITY; INFECTION;
D O I
10.1038/s41541-020-00264-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neutralizing antibody responses of SARS-CoV-2-infected patients may be low and of short duration. We propose here that coronaviruses employ a structural strategy to avoid strong and enduring antibody responses. Other viruses induce optimal and long-lived neutralizing antibody responses, thanks to 20 or more repetitive, rigid antigenic epitopes, spaced by 5-10nm, present on the viral surface. Such arrays of repetitive and highly organized structures are recognized by the immune system as pathogen-associated structural patterns (PASPs), which are characteristic for pathogen surfaces. In contrast, coronaviruses are large particles with long spikes (S protein) embedded in a fluid membrane. Therefore, the neutralizing epitopes (which are on the S protein) are loosely "floating" and widely spaced by an average of about 25nm. Consequently, recruitment of complement is poor and stimulation of B cells remains suboptimal, offering an explanation for the inefficient and short-lived neutralizing antibody responses.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants
    Li, Tingting
    Zhou, Bingjie
    Luo, Zhipu
    Lai, Yanling
    Huang, Suqiong
    Zhou, Yuanze
    Li, Yaning
    Gautam, Anupriya
    Bourgeau, Salome
    Wang, Shurui
    Bao, Juan
    Tan, Jingquan
    Lavillette, Dimitri
    Li, Dianfan
    [J]. FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [42] A design strategy to generate a SARS-CoV-2 RBD vaccine that abrogates ACE2 binding and improves neutralizing antibody responses
    Ratswohl, Christoph
    Vazquez Garcia, Clara
    Ahmad, Ata ul Wakeel
    Gonschior, Hannes
    Lebedin, Mikhail
    Silvis, Casper Ewijn
    Spatt, Lisa
    Gerhard, Cathrin
    Lehmann, Martin
    Sander, Leif E.
    Kurth, Florian
    Olsson, Simon
    de la Rosa, Kathrin
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 (10)
  • [43] A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice
    Powell, Abigail E.
    Zhang, Kaiming
    Sanyal, Mrinmoy
    Tang, Shaogeng
    Weidenbacher, Payton A.
    Li, Shanshan
    Pham, Tho D.
    Pak, John E.
    Chiu, Wah
    Kim, Peter S.
    [J]. ACS CENTRAL SCIENCE, 2021, 7 (01) : 183 - 199
  • [44] Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection
    Muir, Luke
    Jaffer, Aneesa
    Rees-Spear, Chloe
    Gopalan, Vignesh
    Chang, Fernando Y.
    Fernando, Raymond
    Vaitkute, Gintare
    Roustan, Chloe
    Rosa, Annachiara
    Earl, Christopher
    Rajakaruna, Gayathri K.
    Cherepanov, Peter
    Salama, Alan
    McCoy, Laura E.
    Motallebzadeh, Reza
    [J]. KIDNEY INTERNATIONAL REPORTS, 2021, 6 (07): : 1799 - 1809
  • [45] Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa
    Declercq, Jozefien
    Gerlo, Sarah
    Van Nevel, Sharon
    De Ruyck, Natalie
    Holtappels, Gabriele
    Delesie, Liesbeth
    Tobback, Els
    Lammens, Ines
    Gerebtsov, Nikita
    Sedeyn, Koen
    Saelens, Xavier
    Lambrecht, Bart N.
    Gevaert, Philippe
    Vandekerckhove, Linos
    Vanhee, Stijn
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (770)
  • [46] SARS-CoV-2 cellular coinfection is limited by superinfection exclusion
    Sims, Anna
    Weir, Daniel J.
    Cole, Sarah J.
    Hutchinson, Edward
    [J]. JOURNAL OF VIROLOGY, 2025, 99 (04)
  • [47] Adaptive immune responses to SARS-CoV-2 q
    Forthal, Donald
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2021, 172 : 1 - 8
  • [48] The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination
    Seong, Hye
    Yoon, Jin Gu
    Nham, Eliel
    Choi, Yu Jung
    Noh, Ji Yun
    Cheong, Hee Jin
    Kim, Woo Joo
    Kim, Eui Ho
    Kim, Chulwoo
    Han, Young-Hee
    Lim, Sooyeon
    Song, Joon Young
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [49] A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
    Kim, Cheolmin
    Ryu, Dong-Kyun
    Lee, Jihun
    Kim, Young-Il
    Seo, Ji-Min
    Kim, Yeon-Gil
    Jeong, Jae-Hee
    Kim, Minsoo
    Kim, Jong-In
    Kim, Pankyeom
    Bae, Jin Soo
    Shim, Eun Yeong
    Lee, Min Seob
    Kim, Man Su
    Noh, Hanmi
    Park, Geun-Soo
    Park, Jae Sang
    Son, Dain
    An, Yongjin
    Lee, Jeong No
    Kwon, Ki-Sung
    Lee, Joo-Yeon
    Lee, Hansaem
    Yang, Jeong-Sun
    Kim, Kyung-Chang
    Kim, Sung Soon
    Woo, Hye-Min
    Kim, Jun-Won
    Park, Man-Seong
    Yu, Kwang-Min
    Kim, Se-Mi
    Kim, Eun-Ha
    Park, Su-Jin
    Jeong, Seong Tae
    Yu, Chi Ho
    Song, Youngjo
    Gu, Se Hun
    Oh, Hanseul
    Koo, Bon-Sang
    Hong, Jung Joo
    Ryu, Choong-Min
    Park, Wan Beom
    Oh, Myoung-don
    Choi, Young Ki
    Lee, Soo-Young
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [50] Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys
    Wang, Shuang
    Peng, Yun
    Wang, Rongjuan
    Jiao, Shasha
    Wang, Min
    Huang, Weijin
    Shan, Chao
    Jiang, Wen
    Li, Zepeng
    Gu, Chunying
    Chen, Ben
    Hu, Xue
    Yao, Yanfeng
    Min, Juan
    Zhang, Huajun
    Chen, Ying
    Gao, Ge
    Tang, Peipei
    Li, Gang
    Wang, An
    Wang, Lan
    Zhang, Jinchao
    Chen, Shuo
    Gui, Xun
    Yuan, Zhiming
    Liu, Datao
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)